The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk

Journal of Hypertension

Volumn 15, Issue 12 II, 1997, Pages 1579-1592

  Staessen, Jan A ^a,f   Wang, Ji G ^b   Ginocchio, Giuliana ^c   Petrov, Victor ^a   Saavedra, Arturo P ^a   Soubrier, Florent ^d   Vlietinck, Robert ^e   Fagard, Robert ^a  

^a KU LEUVEN DEPARTMENT OF REHABILITATION SCIENCES   (Belgium)

^b FUWAI HOSPITAL   (China)

^c UNIVERSITY OF PADOVA   (Italy)

^d INSERM   (France)

^e UNIVERSITY OF LEUVEN   (Belgium)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Angiotensin II converting enzyme; Cardiomyopathy; Coronary heart disease; Genetic polymorphism; Hypertension; Left ventricle; Nephropathy; Stroke

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; ALLELE; ATHEROSCLEROSIS; BODY MASS; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE INSERTION; HEART DILATATION; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENOVASCULAR DISEASE; STROKE; SYSTOLIC BLOOD PRESSURE;

EID: 0031443817     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715120-00059     Document Type: Conference Paper

References (186)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
2. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992, 20:1433.
3. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al.: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992, 51:197-205.
4. Costerousse O, Allegrini J, Lopez M, Alhenc-Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem J 1993, 290:33-40.
5. Singer DRJ, Missouris CG, Jeffery S: Angiotensin-converting enzyme gene polymorphism. What to do about all the confusion? Circulation 1996, 94:236-239.
6. Re RN, Frohlich ED: Controversies in the genetic analysis of hypertensive diseases. Hypertension 1996, 28:880.
7. Stewart LA, Clarke MJ: Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1996, 14:2057-2079.
8. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR: Publication bias in clinical research. Lancet 1991, 337:867-872.
9. Ravnskov U: Cholesterol lowering trials in coronary heart disease: frequency of citation and outcome. BMJ 1992, 305:15-19.
10. Dickersin K, Berlin JA: Meta-analysis: state-of-the-art science. Epidemiol Rev 1992, 14:154-176.
11. Institute for Scientific Information: Science Citation Index: An International Interdisciplinary Index to the Literature of Science, Medicine, Agriculture, Technology, and the Behavioral and Social Sciences. Philadelphia: Institute for Scientific Information; 1994.
12. Fogarty DG, Maxwell AP, Doherty CC, Hughes AE, Nevin NC: ACE gene typing. Lancet 1994, 343:851-852.
13. Shanmugan V, Sell KW, Saha BK: Mistyping ACE heterozygotes. PCR Methods Appl 1993, 3:120-121.
14. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332:706-711.
15. Khoury MJ, Beaty TH, Cohen BH: Fundamentals of Genetic Epidemiology. Oxford: Oxford University Press; 1993.
16. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959, 22:719-748.
17. Breslow NE, Day NE: Statistical Methods in Cancer Research, Volume 1. The Analysis of Case-Control Studies. IARC Scientific Publications No. 32. Lyon: International Agency for Research on Cancer; 1980.
18. Hedges LV, Olkin I: Tests of statistical significance of combined results. In Statatistical Methods for Meta-analysis, 1st Edn. San Diego: Academic Press/Harcourt Brace Jovanovich Publishers; 1985; 28-47.
19. Badenhop RF, Wang XL, Wilcken DEL: Angiotensin-converting enzyme genotype in children and coronary events in their grandparents. Circulation 1995, 91:1655-1658.
20. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992, 359:641-644.
21. Gu XX, Spaepen M, Guo C, Fagard R, Amery A, Lijnen P, et al.: Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population. J Hum Hypertens 1994, 8:683-685.
22. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
23. Schmidt S, van Hooft IMS, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993, 11:345-348.
24. Arbustini E, Grasso M, Fasani R, Klersy C, Diegoli M, Porcu E, et al.: Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995, 74:584-591.
25. Barley J, Blackwood A, Miller M, Markandu ND, Carter ND, Jeffery S, et al.: Angiotensin converting enzyme gene I/D polymorphism, blood pressure and the renin-angiotensin system in Caucasian and Afro-Caribbean peoples. J Hum Hypertens 1996, 10:31-35.
26. Duru K, Farrow S, Wang JM, Lockerte W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994, 7:759-762.
27. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, et al.: Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Comm 1993, 191:399-404.
28. Johnson AG, Simons LA, Friedlander Y, Simons J, Davis DR, MaCallum J: I/D polymorphism of the angiotensin-converting enzyme gene does not predict isolated systolic or systolic-diastolic hypertension in the elderly. J Hum Hypertens 1996, 10:167-169.
29. Benetos A, Gautier S, Ricard S, Tpouchian J, Asmar R, Poirier O, et al.: Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation 1996, 94:698-703.
30. Morise T, Takeuchi Y, Takeda R: Angiotensin-converting enzyme polymorphism and essential hypertension. Lancet 1994, 343:125.
31. Zee RYL, Lou YK, Griffiths LR, Morris BJ: Association of a polymorphism of the angiotensin I-converting enzyme gene with essential hypertension. Biochem Biophys Res Comm 1992, 184:9-15.
32. Morris BJ, Zee RYL, Schrader AP: Different frequencies of the angiotensin converting enzyme genotypes in older hypertensive individuals. J Clin Invest 1994, 94:1085-1089.
33. Ishigami T, Iwamoto T, Tamura K, Yamaguchi S, Iwasawa K, Uchino K, et al.: Angiotensin I converting enzyme (ACE) gene polymorphism and essential hypertension in Japan: ethnic difference of ACE genotype. Am J Hypertens 1995, 8:95-97.
34. Kamdar S, Daniel H, Fogarty P, Lawson M, Munroe P, Caulfield M: ACE insertion/deletion polymorphism in Vincentian African Caribbeans with essential hypertension [abstract]. J Hum Hypertens 1994, 8:611.
35. Jian M, Cao X, Huang J, Qi J, Liu G, Wang J, et al.: Polymorphism of angiotensin I converting enzyme gene in the older Chinese: linked to ambulatory blood pressure levels and circadian blood pressure rhythm. Int J Cardiol 1996, 55:33-40.
36. Summers KM, West JA, Huggard PR, West MJ: Angiotensin converting enzyme and regulation of blood pressure in a large Australian family. Clin Exp Pharmacol Physiol 1993, 20:320-323.
37. Ukkola O, Savolainen MJ, Salmela PI, von Dickhoff K, Kiema T, Kesäniemi YA: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 1995, 73:307-311.
38. Pujia A, Gnasso A, Irace C, Dominijanni A, Zingone A, Perrotti N, et al.: Association between ACE-D/D polymorphism and hypertension in type II diabetic patients. J Hum Hypertens 1994, 8:687-691.
39. Vassilikioti S, Doumas M, Douma S, Petidis K, Karagiannis A, Balaska K, et al.: Angiotensin converting enzyme gene polymorphism is not related to essential hypertension in a Greek population. Am J Hypertens 1996, 9:700-702.
40. West MJ, Summers KM, Burstow DJ, Wong KK, Huggard PR: Renin and angiotensin-converting enzyme genotypes in patients with essential hypertension and left ventricular hypertrophy. Clin Exp Pharmacol Physiol 1994, 21:207-210.
41. Wierzbicki AS, Nimmo L, Feher MD, Cox A, Foxton J, Lant AF: Association of angiotensin converting enzyme DD genotype with hypertension in diabetes. J Hum Hypertens 1995, 9:671-673.
42. Popov V, Fomicheva E, Kovalev J, Schwartz E: Absence of association between the angiotensin-converting enzyme gene polymorphism and borderline hypertension in men of St Petersburg, Russia. J Hum Hypertens 1996, 10:557-559.
43. Kiema TR, Kauma H, Rantala AO, Lilja M, Reunanen A, Kesäniemi YA, et al.: Variation in angiotensin-converting enzyme gene and angiotensinogen gene loci in relation to blood pressure. Hypertension 1996, 28:1070-1075.
44. Schunkert H, Hense HW, Holmer SR, Slender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
45. Lindpaintner K, Lee M, Larson MC, Rao VS, Pfeffer MA, Ordovas JM, et al.: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1996, 334:1023-1028.
46. Kupari M, Perola M, Koskinen P, Virolainen J, Karhunen PJ: Left ventricular size, mass, and function in relation to angiotensin-converting enzyme gene polymorphism in humans. Am J Physiol 1994, 267:H1107-H1111.
47. Gharavi AG, Lipkowitz MS, Diamond JA, Jhang JS, Phillips RA: Deletion polymorphism of the angiotensin-converting enzyme gene is independently associated with left ventricular mass and geometric remodeling in systemic hypertension. Am J Cardiol 1996, 77:1315-1319.
48. Marian AJ, Yu QT, Workman R, Greve G, Roberts R: Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993, 342:1085-1086.
49. Pfeufer A, Osterziel KJ, Urata H, Borck G, Schuster H, Wienker T, et al.: Angiotensin converting enzyme and chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol 1996, 78:362-364.
50. Danser AHJ, ten Cate FJ, Osterop APRM, Krams R, Derkx FHM, Schalekamp MADH: Lack of association between the insertion/deletion polymorphism of the ACE gene and hypertrophic cardiomyopathy [abstract]. J Hypertens 1996, 14 (suppl 1):S33.
51. Raynolds MV, Bristow MR, Bush EW, Abraham WT, Lowes BD, Zisman LS, et al.: Angiotensin-converting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy. Lancet 1993, 342:1073-1075.
52. Harn HJ, Chang CY, Ho LI, Liu CA, Jeng JR, Lin FG, et al.: Evidence that the polymorphism of the angiotensin I converting enzyme gene may be related to idiopathic dilated cardiomyopathy in the Chinese population. Biochem Mol Biol Int 1995, 35:1175-1181.
53. Sanderson JE, Young RP, Yu CM, Chan S, Critchley JAJH, Woo KS: Lack of association between insertion/deletion polymorphism of the angiotensin-converting enzyme gene and end-stage heart failure due to ischemic or idiopathic dilated cardiomyopathy in the Chinese. Am J Cardiol 1996, 77:1008-1010.
54. Montgomery HE, Keeling PJ, Goldman JH, Humphries SE, Talmud PJ, McKenna WJ: Lack of association between the insertion/deletion polymorphism of the angiotensin-converting enzyme gene and idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1995, 25:1627-1631.
55. Andersson B, Sylvén C: The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. J Am Coll Cardiol 1996, 28:162-167.
56. Tiret L, Kee F, Poirier O, Nicaud V, Lecerf L, Evans A, et al.: Deletion polymorphism in angiotensin-converting enzyme gene associated with parental history of myocardial infarction. Lancet 1993, 341:991-992.
57. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and parental history of myocardial infarction. Clin Genet 1993, 44:298-301.
58. Bøhn M, Berge KE, Bakken A, Erikssen J, Berg K: Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993, 44:292-297.
59. Evans AE, Poirier O, Kee F, Lecerf L, McCrum E, Falconer T, et al.: Polymorphisms of the angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. QJM 1994, 87:211-214.
60. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F: A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population. Atherosclerosis 1995, 112:137-143.
61. Zhao Y, Higashimori K, Higaki J, Kamitani A, Ohishi M, Katsuya T, et al.: Significance of the deletion polymorphism of the angiotensin converting enzyme gene as a risk factor for myocardial infarction in Japanese. Hypertens Res 1994, 17:55-57.
62. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, et al.: Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with serum ACE concentration and increased risk for CAD in Japanese. Circulation 1994, 90:2199-2202.
63. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel JM, Ward RH: Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995, 91:2120-2124.
64. Ruiz J, Blanche H, Cohen N, Velho G, Cambien F, Cohen D: Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1994, 91:3662-3665.
65. Gardemann A, Weiss T, Schwartz O, Eberbach A, Katz N, Hehrlein FW, et al.: Gene polymorphism but not catalytic activity of angiotensin I-converting enzyme is associated with coronary heart disease and myocardial infarction in low-risk patients. Circulation 1995, 92:2796-2799.
66. Schuster H, Wienker WF, Stremmler U, Noll B, Steinmetz A, Luft FC: An angiotensin-converting enzyme gene variant is associated with acute myocardial infarction in women, but not in men. Am J Cardiol 1995, 76:601-603.
67. Beohar N, Damaraju S, Prather A, Yu QT, Raizner AE, Kleiman NS, et al.: Angiotensin converting enzyme genotype DD is a risk factor for coronary heart disease. J Invest Med 1995, 43:275-280.
68. Keavney BD, Dudley CRK, Stratton IM, Holman RR, Matthews DR, Ratcliffe PJ, et al.: UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 1995, 38:948-952.
69. Fujisawa T, Ikegami H, Shen GQ, Yamato E, Takekawa K, Nakagawa Y, et al.: Angiotensin-I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM. Diabetes Care 1995, 18:983-985.
70. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi SJ, Takami S, et al.: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995, 25: 950-953.
71. Wang XL, McCredie RM, Wilcken DEL: Genotype distribution of angiotensin-converting enzyme polymorphism in Australian healthy and coronary populations and relevance to myocardial infarction and coronary heart disease. Arterioscler Thromb Vasc Biol 1996, 16:115-119.
72. Leatham E, Barley J, Redwood S, Hussein W, Carter N, Jeffery S, et al.: Angiotensin-1 converting enzyme (ACE) polymorphism in patients presenting with myocardial infarction or unstable angina. J Hum Hypertens 1994, 8:635-638.
73. Samani NJ, O'Toole L, Martin D, Rai H, Fletcher S, Lodwick D, et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of and prognosis after myocardial infarction. J Am Coll Cardiol 1996, 28:338-344.
74. Ahnve S, Rodin T, Berglund L, Eggertsen G, Sylvén C: Angiotensin converting enzyme gene polymorphism in acute myocardial infarction patients [abstract]. J Am Coll Cardiol 1995, 25:276A-277A.
75. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al.: Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995, 345:1600-1603.
76. Mattu RK, Needham EWA, Gallon DJ, Frangos E, Clark AJL, Caulfield M: A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 1995, 91:270-274.
77. Miettinen HE, Korpela K, Hämäläinen L, Kontula K: Polymorphisms of the apolipoprotein and angiotensin converting enzyme genes in young North Karelian patients with coronary heart disease. Hum Genet 1994, 94:189-192.
78. Panahloo A, Andres C, Mohamed-Ali V, Gould MM, Talmud P, Humphries SE, et al.: The insertion allele of the ACE gene I/D polymorphism. A candidate gene for insulin resistance? Circulation 1995, 92:3390-3393.
79. Nakata Y, Katsuya T, Rakugi H, Takami S, Ohishi M, Kamino K, et al.: Polymorphism of the apolipoprotein E and angiotensin-converting enzyme genes in Japanese subjects with silent myocardial ischemia. Hypertension 1996, 27:1205-1209.
80. Kaski JC, Zhang Y, Calviño R, Vazquez-Rodriguez JM, Castro-Beiras A, Jeffery S, et al.: Angiotensin-converting enzyme insertion/deletion polymorphism and restenosis after coronary angioplasty in unstable angina pectoris. Am J Cardiol 1995, 77:875-879.
81. Zhang Y, Jeffery S, Barley J, Hann C, Carter N, Kaski JC: Angiotensin-converting enzyme insertion/deletion polymorphism in angina pectoris with normal coronary angiograms. Am J Cardiol 1996, 77:877-879.
82. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al.: Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 1995, 38:798-803.
83. Winkelmann BR, Nauck M, Klein B, Russ AP, Böhm BO, Siekmeier R, et al.: Deletion polymorphism of the angiotensin I-converting enzyme is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk of myocardial infarction and coronary heart disease. Ann Intern Med 1996, 125:19-25.
84. Dike Y, Hata A, Ogata Y, Numata Y, Shido K, Kondo K: Angiotensin converting enzyme as a genetic risk factor for coronary artery spasm: implications in the pathogenesis of myocardial infarction. J Clin Invest 1995, 96:2975-2979.
85. Ueda S, Weir CJ, Inglis GC, Murray GD, Muir KW, Lees KR: Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke. J Hypertens 1995, 13:1597-1601.
86. Watanabe Y, Ishigami T, Iwamoto T, Tamura K, Yoshimura H, Sawada R, et al.: Association analysis of polymorphism for the angiotensin converting enzyme gene in patients with cerebral infarction in Japan [abstract]. J Hypertens 1996, 14 (suppl 1):S32.
87. Kario K, Kanai N, Saito K, Nago N, Takefumi M, Shimada K: Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives. Circulation 1996, 93:1630-1633.
88. Sharma P, Carter ND, Barley J, Brown MM: Molecular approach to assessing the genetic risk of cerebral infarction: deletion polymorphism in the gene encoding angiotensin 1-converting enzyme. J Hum Hypertens 1994, 8:645-648.
89. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, et al.: Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995, 26:1329-1333.
90. Ohishi M, Fujii K, Minamino T, Higaki J, Kamitani A, Rakugi H, et al.: A potent genetic risk factor for restenosis. Nat Genet 1993, 5:324-325.
91. Hamon M, Bauters C, Amant C, McFadden EP, Helbecque N, Lablanche JM, et al.: Relation between the deletion polymorphism of the angiotensin-converting enzyme gene and late luminal narrowing after coronary angioplasty. Circulation 1995, 92:296-299.
92. Missouris CG, Barley J, Jeffery S, Carter ND, Singer DRJ, MacGregor GA: Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin 1-converting enzyme gene. Kidney Int 1996,49:534-537.
93. Dessi-Fulgheri P, Catalini R, Sarzani R, Sturbini S, Siragusa N, Guazzarotti F, et al.: Angiotensin converting enzyme gene polymorphism and carotid atherosclerosis in a low-risk population. J Hypertens 1995, 13:1593-1596.
94. Tarnow L, Cambien F, Rossing P, Nielsen FS, Hansen BV, Lecerf L, et al.: Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 1995, 44:489-494.
95. Harden PN, Geddes C, Rowe PA, McIlroy JH, Boulton-Jones M, Rodger RSC, et al.: Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy. Lancet 1995, 345:1540-1542.
96. Yorioka T, Suehiro T, Yasuoka N, Hashimoto K, Kawada M: Polymorphism of the angiotensin converting enzyme gene and clinical aspects of IgA nephropathy. Clin Nephrol 1995, 44:80-85.
97. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, et al.: Relationships between angiotensin I-converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 1994, 43:384-388.
98. Doria A, Warram JH, Krowelski AS: Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I converting enzyme gene. Diabetes 1994, 43:690-695.
99. Nomura H, Koni I, Michishita Y, Morise T, Takeda R: Angiotensin-converting enzyme gene polymorphism in haemodialysis patients. Lancet 1994, 343:482-483.
100. Doi Y, Yoshizumi H, Yoshinari M, Iino K, Yamamoto M, Ichikawa K, et al.: Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in the Japanese patients with NIDDM. Diabetologia 1996, 39:97-102.
101. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ: UK Prospective Diabetes Study XV: relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 1995, 48:1907-1911.
102. Mizuiri S, Hemmi H, Inoue A, Yoshikawa H, Tanegashima M, Fushimi T, et al.: Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 1995, 70:455-459.
103. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, et al.: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995, 96:2162-2169.
104. Schmidt S, Schöne N, Ritz E, The Diabetic Nephropathy Study Group: Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 1995, 47:1176-1181.
105. Marre M, Jeunemaitre X, Gallois Y, Rodier M, Chatellier G, Sert C, et al.: Contribution of genetic polymorphisms in the renin-angiotensin system to the development of renal complications in insulin-dependent diabetes. Génétique de la Néphropathie Diabétique (GENEDIAB) Study Group. J Clin Invest 1997, 99:1585-1595.
106. Fogarty DG, Hughes AE, Nevin NC, Doherty CC, Maxwell AP: Functional genetic markers of the renin-angiotensin system and the risk of diabetic retinopathy in insulin-dependent diabetes mellitus [abstract]. J Am Soc Nephrol 1994, 5:376.
107. Kitamura H, Moriyama T, Izumi M, Yokoyama K, Yamauchi A, Ueda N, et al.: Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology. Kidney Int 1996, 49 (suppl 55):S101-S103.
108. Yoshida H, Kuriyama S, Atsumi Y, Tomonari H, Mitarai T, Hamaguchi A, et al.: Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 1996, 50:657-664.
109. Hunley TE, Julian BA, Phillips JA III, Summar ML, Yoshida H, Horn RG, et al.: Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996, 49:571-577.
110. Schmidt S, Stier E, Hartung R, Stein G, Bahnisch J, Woodroffe AJ, et al.: No association of converting enzyme insertion/deletion polymorphism with immunoglobulin A glomerulonephritis. Am J Kidney Dis 1995, 26:727-731.
111. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones JM, Connell JMC, Jardine AG: The role of genetic polymorphisms of the angiotensin-converting enzyme in the progression of renal diseases. Hypertension 1996, 28:912-915.
112. van Essen GG, Rensma PL, de Zeeuw D, Sluiter WJ, Scheffer H, Apperloo AJ, et al.: Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy. Lancet 1996, 347:94-95.
113. Bloem LJ, Manatunga AK, Pratt JH: Racial difference in the relationship of an angiotensin I-converting enzyme gene polymorphism to serum angiotensin I-converting enzyme activity. Hypertension 1996, 27:62-66.
114. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, et al.: Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 1994, 90:669-676.
115. Lee EJD: Population genetics of the angiotensin-converting enzyme in Chinese. Br J Clin Pharmacol 1994, 37:212-214.
116. Pinto YM, van Gilst WH, Kingma JH, Schunkert H, for the Captopril and Thrombolysis Study Investigators: Deletion-type allele of the angiotensin-converting enzyme gene is associated with progressive ventricular dilation after myocardial infarction. J Am Coll Cardiol 1995, 25:1622-1626.
117. Sharma P, Carter ND, Barley J, Lunt R, Seymour CA, Brown MM: Polymorphisms in the gene encoding angiotensin 1-converting enzyme and the relationship to its post-translational product in cerebral infarction. J Hum Hypertens 1994, 8:633-634.
118. McKenzie CA, Julier C, Forrester T, McFarlane-Anderson N, Keavney B, Lathrop GM, et al.: Segregation and linkage analysis of serum angiotensin I-converting enzyme levels: evidence for two quantitative-trait loci. Am J Hum Genet 1995, 57:1426-1435.
119. Hosoi M, Nishizawa Y, Kogawa K, Kawagishi T, Konishi T, Maekawa K, et al.: Angiotensin-converting enzyme gene is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients. Circulation 1996, 94:704-707.
120. Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H, Manabe K, et al.: Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode amd pulsed Doppler echocardiographic studies. J Hypertens 1996, 14:1403-1408.
121. Kojima S, Inenaga T, Matsuoka H, Kuramochi M, Omae T, Nara Y, et al.: The association between salt sensitivity of blood pressure and some polymorphic factors. J Hypertens 1994, 12:797-801.
122. Dieguez-Lucena JL, Aranda-Lara P, Riuz-Galdón M, García-Villanova J, Morell-Ocaña M, Reyes-Engel A: Angiotensin I-converting enzyme genotypes and angiotensin II receptors. Response to therapy. Hypertension 1996, 28:98-103.
123. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JEC, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995, 13:1602-1609.
124. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P: Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of renin-angiotensin system genes. J Hypertens 1996, 14:259-262.
125. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M: DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994, 90:2622-2628.
126. Zingone A, Dominijanni A, Mele E, Marasco O, Melina F, Minchella P, et al.: Deletion polymorphism in the gene for angiotensin converting enzyme is associated with elevated fasting blood sugar levels. Hum Genet 1994, 94:207-209.
127. Castellano M, Mulesan ML, Rizzoni D, Beschi M, Pasini G, Cinelli A, et al.: Angiotensin-converting enzyme I/D polymorphism and arterial wall thickness in general population. The Vobarno study. Circulation 1995, 91:2721-2724.
128. Berge KE, Berg K: No effect of insertion/deletion polymorphism at the ACE locus on normal blood pressure level or variability. Clin Genet 1994, 45:169-174.
129. Lechin M, Quiñones MA, Omran A, Hill R, Yu QT, Rakowski H, et al.: Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy. Circulation 1995, 92:1808-1812.
130. Perticone F, Pugliese F, Ceravolo R, Cosco C, Trapasso MP, Perrotti N, et al.: Association of angiotensin converting enzyme gene with blood pressure variability and left ventricular mass [abstract]. J Hypertens 1996, 14 (suppl 1):S30.
131. O'Kane KPJ, Mayet J, Thom S, Webb DJ: Left ventricular hypertrophy is independent of ACE genotype in untreated essential hypertension [abstract]. J Hypertens 1996, 14 (suppl 1):S31.
132. Prasad N, O'Kane KPJ, Johnstone HA, Wheeldon NM, McMahon AD, Webb DJ, et al.: The relationship between blood pressure and left ventricular mass in essential hypertension is observed only in the presence of the angiotensin-converting enzyme deletion allele. QJM 1994, 87:659-662.
133. Parving HH, Jacobsen P, Tarnow L, Rossing P, Lecerf L, Poirier O, et al.: Deleterious effect of a deletion polymorphism in angiotensin-converting enzyme gene on progression of diabetic nephropathy during angiotensin-converting enzyme inhibition. BMJ 1996, 313:591-594.
134. Celermajer DS, Sorensen KE, Barley J, Jeffrey S, Carter N, Deanfield J: Angiotensin-converting enzyme genotype is not associated with endothelial dysfunction in subjects without other coronary risk factors. Atherosclerosis 1994, 111:121-126.
135. Castellano M, Muiesan ML, Beschi M, Rizzoni D, Pasini G, Salvetti M, et al.: ACE insertion/deletion polymorphism is associated with carotid artery intima-media thickness, but not left ventricular mass, in a general population [abstract]. J Hypertens 1996, 14 (suppl 1):S213.
136. Clifford CP, Nunez DJR: Racial differences in the frequency of a restriction site polymorphism of the angiotensin converting enzyme (ACE) gene [abstract]. J Hypertens 1996, 14 (suppl 1):S13.
137. Young RP, Sanderson JE, Tomlinson B, Woo KS, Critchley AJH: Angiotensin converting enzyme insertion-deletion polymorphism in Chinese. J Hypertens 1995, 13:1479-1483.
138. Samani NJ, Martin DS, Brack M, Cullen J, Chauhan A, Lodwick D, et al.: Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995, 345:1013-1016.
139. Rotimi C, Puras A, Cooper R, McFarlane-Anderson N, Forrester T, Ogunbiyi O, et al.: Polymorphisms of renin-angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 1996, 27:558-563.
140. Hiraga H, Oshima T, Watanabe M, Ishida M, Ishida T, Shingu T, et al.: Angiotensin I-converting enzyme gene polymorphism and salt sensitivity in essential hypertension. Hypertension 1996, 27:569-572.
141. Barley J, Blackwood A, Carter ND, Crews DE, Cruickshank JK, Jeffery S, et al.: Angiotensin converting enzyme insertion/deletion polymorphism: association with ethnic origin. J Hypertens 1994, 12:955-957.
142. Ohishi M, Rakugi H, Ogihara T: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 331:1097-1098.
143. Danser AHJ, Schalekamp MADH, Bax WA, Maassen van den Brink A, Saxena PR, Riegger GAJ, et al.: Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 1995, 92:1387-1388.
144. Lachurié ML, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J: Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995, 91:2933-2942.
145. Ueda S, Elliott HL, Morton JJ, Connell JMC: Enhanced pressor response to angiotensin I in normotensive men with the deletion genotype (DD) for angiotensin-converting enzyme. Hypertension 1995, 25:1266-1269.
146. Hegele RA, Brunt JH, Connell JMC: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212.
147. Schächter F, Faure-Delanef L, Guénot F, Rouger H, Froguel P, Lesueur-Ginot L, et al.: Genetic associations with human longevity at the APOE and ACE loci. Nat Genet 1994, 6:29-32.
148. Talmud PJ, Watts GF, McBride S, Mandalia S, Brunt JNH, Coltart DJ, et al.: Angiotensin converting enzyme gene polymorphism and the course of angiographically defined coronary artery disease. Atherosclerosis 1995, 114:133-135.
149. Ohmichi N, Iwai N, Nakamura Y, Kinoshita M: The genotype of the angiotensin-converting enzyme gene and global left ventricular dysfunction after myocardial infarction. Am J Cardiol 1995, 76:326-329.
150. Ohmichi N, Iwai N, Maeda K, Shimoike H, Nakamura Y, Izumi M, et al.: Genetic basis of left ventricular remodeling after myocardial infarction. Int J Cardiol 1996, 53:265-272.
151. Rasmussen LM, Ledet T: Aortic atherosclerosis in diabetes mellitus is associated with insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. No relation between polymorphism and aortic collagen content. Diabetologia 1996, 39:696-700.
152. Rutledge DR, Browe CS, Ross EA: Frequencies of the angiotensinogen gene and angiotensin I converting anzyme (ACE) gene in African Americans. Biochem Mol Biol Int 1994, 34:1271-1275.
153. Suzuki T, Yokota H, Yamazaki T, Kitamura K, Yamaoki K, Nagai R, et al.: Angiotensin converting enzyme polymorphism is associated with severity of coronary heart disease and serum lipids (total cholesterol and triglycerides levels) in Japanese patients. Coronary Artery Dis 1996, 7:371-375.
154. Chowdhury TA, Dronsfield MJ, Kumar S, Gough SLC, Gibson SP, Khatoon A, et al.: Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with diabetic nephropathy in IDDM. Diabetologia 1996, 39:1108-1114.
155. Kauma H, Päivänsalo M, Savolainen MJ, Rantala AO, Kiema TR, Lilja M, et al.: Association between angiotensin converting enzyme gene and polymorphism and carotid atherosclerosis. J Hypertens 1996, 14:1183-1187.
156. Seglen PO: Why the impact factor of journals should not be used for evaluating research. BMJ 1997, 314:212-216.
157. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL: A metaanalysis of the association of the deletion allele of the angiotensin-converting enzyme with myocardial infarction. Circulation 1996, 94:708-712.
158. Alhenc-Gelas F, Richard J, Courbon C, Warnet JM, Corvol P: Distribution of plasma angiotensin I converting enzyme levels in healthy men. J Lab Clin Med 1991, 117:33-39.
159. Müller DN, Bohlender J, Hilgers KF, Dragun D, Costerousse O, Ménard J, et al.: Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 1997, 29:98-104.
160. Oparil S, Tregear GW, Koerner TJ, Barnes BA, Haber E: Mechanism of pulmonary conversion of angiotensin I to II in the dog. Circ Res 1971, 29:682-690.
161. Sealey JE, James GD, Laragh JH: The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium homeostasis. In Hypertension. Pathophysiology, Diagnosis and Management 2nd Edn. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1995:1763-1796.
162. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, et al.: Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993, 91:1269-1281.
163. Arnal JF, Battle T, Rasetti C, Challah M, Costerousse O, Vicaut E, et al.: ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994, 267:H1777-H1784.
164. Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH: Increased rat cardiac angiotensin converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy: effects on coronary resistance, contractility and relaxation. J Clin Invest 1990, 86:1913-1920.
165. Okamura T, Miyazaki M, Inagami T, Toda N: Vascular renin angiotensin system in two kidney, one clip hypertensive rats. Hypertension 1986, 8:560-565.
166. Powell JS, Clozel JP, Müller RKM, Kuhn H, Hefti F, Hosang M, et al.: Inhibitors of angiotensin-converting enzyme prevent myointimal proliferation after vascular injury. Science 1989, 245:186-188.
167. Rakugi H, Wang DS, Dzau VJ, Pratt RE: Potential importance of tissue angiotensin-converting enzyme inhibition in preventing neointimal proliferation. Circulation 1994, 90:449-155.
168. Kato H, Suzuki H, Tajima S, Ogata Y, Tominaga T, Sato A, et al.: Angiotensin II stimulates collagen synthesis in cultured vascular smooth muscle cells. J Hypertens 1991, 9:17-22.
169. Morishita R, Gibbons GH, Kaneda Y, Ogihara T, Dzau VJ: Novel and effective gene transfer technique for study of vascular renin angiotensin system. J Clin Invest 1993, 91:2580-2585.
170. Stehouwer CDA, Nauta JJ, Zeldenrust GC, Hackeng WH, Donder AJ, den Ottolander GJ: Urinary albumin excretion, cardiovascular disease and endothelial dysfunction in non-insulin dependent diabetes mellitus. Lancet 1992, 340:319-323.
171. Lorenzi M, Cagliero E: Pathobiology of endothelial and other vascular cells in diabetes mellitus: call for data. Diabetes 1991, 40:653-659.
172. Erdös EG: Angiotensin I converting enzyme and the changes in our concepts through the years. Hypertension 1990, 16:363-370.
173. Sharpe N, Murphy J, Smith H, Hannon S: Treatment of patients with symptomless left ventricular dysfunction after myocardial infarction. Lancet 1988, i:255-259.
174. Sharpe N, Smith H, Murphy J, Greaves S, Hart H, Gamble G: Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition. Lancet 1991, 337:872-876.
175. Pfeffer MA, Braunwald E, Moyé LA, Basta L, Brown EJ Jr, Cuddy TE, et al.: Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992, 327:669-677.
176. Marre M, Chatellier G, Leblanc H, Guyene TT, Ménard J, Passa P: Prevention of diabetic nephropathy with enalapril in normotensive diabetics with microalbuminuria. BMJ 1988, 297:1092-1095.
177. Ravid M, Lang R, Rachmani R, Lishner M: Long-term renoprotective effect of inhibition of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. Arch Intern Med 1996, 156:286-289.
178. Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al.: Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet 1995, 346:1080-1084.
179. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M: Long-term stabilizing effect of angiotensin converting-enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993, 118:577-581.
180. Lewis EJ, Hunsicker LG, Bain RP, Rohde RP, for the Collaborative Study Group: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993, 329:1456-1462.
181. Kagan A, Poper JS, Rhoads GG, Yano K: Dietary and other risk factors for stroke in Hawaiian Japanese men. Stroke 1985, 16:390-396.
182. Herman B, Schulte BPM, Van Luijk JH, Leyten ACM, Franken CWGM: Epidemiology of stroke in Tilburg, The Netherlands. The Population-Based Stroke Incidence Register: 1. Introduction and preliminary results. Stroke 1980, 11:162-165.
183. The French Study of Aortic Plaques in Stroke Group: Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. N Engl J Med 1996, 334:1216-1221.
184. Amarenco P, Cohen A, Tzourio C, Bertrand B, Hommel M, Besson G, et al.: Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994, 331:1474-1479.
185. Fagard RH: Reversibility of left ventricular hypertrophy by antihypertensive drugs. Neth J Med 1995, 47:173-179.
186. Paul M, Pinto YM, Schunkert H, Ganten D, Böhm M: Activation of the renin-angiotensin system in heart failure and hypertrophy - studies in human hearts and transgenic rats. Eur Heart J 1994, 15 (suppl D):63-67.